Three contractors helping build the migrant detention center dubbed Alligator Alcatraz have reportedly donated money to the ...

From minimally invasive surgery through robotic technology to regenerative medicine with stem cells, and the increasingly ...

Astronauts aboard the ISS resumed critical research on brain circulation, cancer cell behaviour, and space biotechnology. The ...

Knoxville lawyer Jeff Hagood has been nominated to the Tennessee Valley Authority Board of Directors by President Donald ...

In soil remediation processes, the mediating role of microorganisms in soil nutrient cycling is critical. The decline in ...

Rising concern about environmental pollution due to traditional plastic packaging and growing demand for food safety have promoted the emergence of ...

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

“I’m truly delighted to join the Board of Directors at Ability Biotherapeutics,” said Dr. Maki. “Ability’s bold mission to revolutionize targeted antibody therapies for cancer and autoimmune diseases, ...

[email protected] Media contact: DJ Webster [email protected] The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity ...

Company News Published 01/08/2025, 09:05 AM 0 Vor Bio expands board with new director Erez Kalir VOR -3.64% ...